Location: Miami, FL
CIK: 0001325083 · Show all filings
Period: Q1 2015 (← Previous) (Next →)
Filing Date: May 15, 2015
Total Value: $343M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Medivation, Inc. | 2,198,919 | $284M | 82.6% | $49.20 | — | COM | 58501N101 |
| — | Ampio Pharmaceuticals Inc. | 3,388,322 | $25.51M | 7.4% | $6.03 | — | COM | 03209T109 |
| — | Synthetic Biologics Inc. | 3,400,816 | $7.448M | 2.2% | $1.48 | — | COM | 87164U102 |
| — | Alcobra Ltd | 1,115,315 | $6.279M | 1.8% | $7.08 | — | SHS | M2239P109 |
| — | Newlink Genetics Corp | 102,437 | $5.604M | 1.6% | $27.98 | — | COM | 651511107 |
| — | Advaxis Inc. | 275,000 | $3.971M | 1.2% | $14.44 | — | COM NEW | 007624208 |
| — | Keryx Biopharmaceuticals Inc. | 200,000 | $2.546M | 0.7% | $10.21 | — | COM | 492515101 |
| — | Bio Blast Pharma Ltd | 338,110 | $2.029M | 0.6% | $7.27 | — | SHS | M20156101 |
| ALDX | Aldeyra Therapeutics Inc | 135,800 | $1.382M | 0.4% | $10.20 | 0.0% | COM | 01438T106 |
| — | Lion Biotechnologies Inc | 100,000 | $1.211M | 0.4% | $12.11 | — | COM | 53619R102 |
| — | Advaxis Inc. | 112,500 | $1.17M | 0.3% | $10.40 | — | W EXP 07/15/201 | 007624117 |
| — | PlasmaTech Biopharmaceutical | 213,100 | $669K | 0.2% | $3.14 | — | COM | 72754H109 |
| — | Galmed Pharmaceuticals Ltd | 65,000 | $612K | 0.2% | $11.48 | — | SHS | M47238106 |
| — | OHR Pharmaceutical Inc | 205,000 | $521K | 0.2% | $2.54 | — | COM NEW | 67778H200 |
| — | Evoke Pharma Inc | 53,839 | $380K | 0.1% | $7.06 | — | COM | 30049G104 |
| — | Zosano Pharma Corp | 20,000 | $202K | 0.1% | $10.10 | — | COM | 98979H103 |
| — | Aptose Biosciences Inc | 20,000 | $108K | 0.0% | $5.40 | — | COM NEW | 03835T200 |